50 reports of this reaction
2.9% of all PYRITHIONE ZINC reports
#4 most reported adverse reaction
DRY SKIN is the #4 most commonly reported adverse reaction for PYRITHIONE ZINC, manufactured by Wal-Mart Stores Inc. There are 50 FDA adverse event reports linking PYRITHIONE ZINC to DRY SKIN. This represents approximately 2.9% of all 1,712 adverse event reports for this drug.
Patients taking PYRITHIONE ZINC who experience dry skin should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRY SKIN is a less commonly reported adverse event for PYRITHIONE ZINC, but still significant enough to appear in the safety profile.
In addition to dry skin, the following adverse reactions have been reported for PYRITHIONE ZINC:
The following drugs have also been linked to dry skin in FDA adverse event reports:
DRY SKIN has been reported as an adverse event in 50 FDA reports for PYRITHIONE ZINC. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRY SKIN accounts for approximately 2.9% of all adverse event reports for PYRITHIONE ZINC, making it a notable side effect.
If you experience dry skin while taking PYRITHIONE ZINC, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.